Transdermal iontophoretic delivery of hydrocortisone from cyclodextrin solutions

被引:26
作者
Chang, SL [1 ]
Banga, AK [1 ]
机构
[1] Auburn Univ, Sch Pharm, Dept Pharmacal Sci, Auburn, AL 36849 USA
关键词
D O I
10.1111/j.2042-7158.1998.tb06897.x
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Enhanced skin penetration of hydrocortisone can be desirable for treatment of several diseases. Transdermal iontophoretic delivery of hydrocortisone solubilized in an aqueous solution of hydroxypropyl-beta-cyclodextrin (HP-beta-CyD) was investigated and compared with chemical enhancement of co-solvent formulations. The passive permeation of hydrocortisone through human cadaver skin was higher when delivered from propylene glycol than when delivered after solubilization in an aqueous solution of HP-beta-CyD, However, the iontophoretic delivery of the 1% hydrocortisone-9% HP-beta-CyD solution was higher than the amount delivered passively by the 1% hydrocortisone-propylene glycol formulation, even if oleic acid was used as a chemical enhancer. Iontophoretic delivery of 1% hydrocortisone with 3% or 15% HP-beta-CyD was lower than that of the 9% HP-beta-CyD solution. These data suggest that free hydrocortisone rather than complexes is predominantly delivered iontophoretically through the skin and the HP-beta-CyD complex serves as a carrier to replenish depletion of hydrocortisone. HP-beta-CyD prevents hydrocortisone from forming a skin reservoir. Iontophoresis provides better enhancement of transdermal delivery of hydrocortisone than the chemical approach when just sufficient HP-beta-CyD is added to solubilize the hydrocortisone.
引用
收藏
页码:635 / 640
页数:6
相关论文
共 15 条
[1]
ARIMURA T, 1990, NTT REVIEW, V2, P155
[2]
IONTOPHORETIC DELIVERY OF DRUGS - FUNDAMENTALS, DEVELOPMENTS AND BIOMEDICAL APPLICATIONS [J].
BANGA, AK ;
CHIEN, YW .
JOURNAL OF CONTROLLED RELEASE, 1988, 7 (01) :1-24
[3]
Effect of novel penetration enhancers on the transdermal delivery of hydrocortisone: An in vitro species comparison [J].
Fuhrman, LC ;
Michniak, BB ;
Behl, CR ;
Malick, AW .
JOURNAL OF CONTROLLED RELEASE, 1997, 45 (02) :199-206
[4]
The role of electroosmotic flow on in-vitro transdermal iontophoresis [J].
Lin, RY ;
Ou, YC ;
Chen, WY .
JOURNAL OF CONTROLLED RELEASE, 1997, 43 (01) :23-33
[5]
THE EFFECT OF POLYVINYLPYRROLIDONE AND HYDROXYPROPYL METHYLCELLULOSE ON HP-BETA-CD COMPLEXATION OF HYDROCORTISONE AND ITS PERMEABILITY THROUGH HAIRLESS MOUSE SKIN [J].
LOFTSSON, T ;
SIGUROARDOTTIR, AM .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 2 (04) :297-301
[6]
THE INFLUENCE OF 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN ON DIFFUSION RATES AND TRANSDERMAL DELIVERY OF HYDROCORTISONE [J].
LOFTSSON, T ;
FRIORIKSDOTTIR, H ;
INGVARSDOTTIR, G ;
JONSDOTTIR, B ;
SIGUROARDOTTIR, AM .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1994, 20 (09) :1699-1708
[7]
AZONE ANALOGS AS PENETRATION ENHANCERS - EFFECT OF DIFFERENT VEHICLES ON HYDROCORTISONE ACETATE SKIN PERMEATION AND RETENTION [J].
MICHNIAK, BB ;
PLAYER, MR ;
CHAPMAN, JM ;
SOWELL, JW .
JOURNAL OF CONTROLLED RELEASE, 1994, 32 (02) :147-154
[8]
THE ROLE OF ELECTROOSMOTIC FLOW IN TRANSDERMAL IONTOPHORESIS [J].
PIKAL, MJ .
ADVANCED DRUG DELIVERY REVIEWS, 1992, 9 (2-3) :201-237
[9]
PREISS A, 1995, PHARMAZIE, V50, P121
[10]
COMPLEXATION OF HYDROCORTISONE WITH BETA-CYCLODEXTRIN AND HYDROXYPROPYL-BETA-CYCLODEXTRIN [J].
PREISS, A ;
MEHNERT, W ;
FROMMING, KH .
ARCHIV DER PHARMAZIE, 1994, 327 (11) :729-734